ALDH2 and androgen insensitivity syndrome: Preliminary validation using serum from acute IS (AIS) patients and healthy controls showed significantly altered levels of ALDH2, ITGA5, KYNU, and TFRC, with TFRC exhibiting promising diagnostic performance both individually (AUC = 0.816) and in combination with the other three biomarkers (AUC = 0.876).